A central characteristic shared by ALPS patients and lpr/lpr Fas-deficient mice is the development of lymphoproliferative disease, characterized by splenomegaly, lymphadenopathy and accumulation of CD4−CD8− DN T cells3, 4. This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.